{"id":"https://openalex.org/W2183715633","doi":null,"title":"Characterization of metastatic breast cancer lesions with ferumoxytol MRI and clinical response to MM-398, nanoliposomal irinotecan (nal-IRI), in 3 subjects","display_name":"Characterization of metastatic breast cancer lesions with ferumoxytol MRI and clinical response to MM-398, nanoliposomal irinotecan (nal-IRI), in 3 subjects","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2183715633","mag":"2183715633"},"language":"en","primary_location":{"id":"mag:2183715633","doi":null,"is_oa":false,"landing_page_url":"http://merrimackpharma.com/sites/default/files/documents/SABCS2014_563_Sachdev%20et%20al_v7.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055462512","display_name":"Jasgit C. Sachdev","orcid":"https://orcid.org/0000-0002-4408-7617","observed_orcids":["https://orcid.org/0000-0002-4408-7617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jasgit C. Sachdev","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4408-7617","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113733729","display_name":"Ramesh K. Ramanathan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramesh K. Ramanathan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435181","display_name":"Natarajan Raghunand","orcid":"https://orcid.org/0000-0002-8893-7687","observed_orcids":["https://orcid.org/0000-0002-8893-7687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natarajan Raghunand","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8893-7687","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jaeyeon Kim","orcid":"https://orcid.org/0000-0003-2811-8281","observed_orcids":["https://orcid.org/0000-0003-2811-8281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaeyeon Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2811-8281","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054166052","display_name":"Stephan G. Klinz","orcid":"https://orcid.org/0000-0001-7354-3346","observed_orcids":["https://orcid.org/0000-0001-7354-3346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephan G. Klinz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7354-3346","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048957048","display_name":"Eliel Bayever","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eliel Bayever","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109881019","display_name":"Jonathan B. Fitzgerald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan B. Fitzgerald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004915418","display_name":"Ronald Lee Korn","orcid":"https://orcid.org/0000-0003-1141-5749","observed_orcids":["https://orcid.org/0000-0003-1141-5749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald L. Korn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1141-5749","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17925987,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.8916000127792358,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.8916000127792358,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.04859999939799309,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12405","display_name":"Characterization and Applications of Magnetic Nanoparticles","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/nanoliposomal-irinotecan","display_name":"nanoliposomal irinotecan","score":0.9890000224113464},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.7179999947547913},{"id":"https://openalex.org/keywords/mri-contrast-agents","display_name":"MRI contrast agents","score":0.40700000524520874},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5239999890327454},{"id":"https://openalex.org/keywords/breast-cancer-imaging","display_name":"breast cancer imaging","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8116118907928467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7807484865188599},{"id":"https://openalex.org/C2909801847","wikidata":"https://www.wikidata.org/wiki/Q411235","display_name":"Ferumoxytol","level":3,"score":0.6850003600120544},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.60445636510849},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.47577348351478577},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4690419137477875},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.4365842938423157},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43184763193130493},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.42719414830207825},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4134727716445923},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11385846138000488}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2183715633","doi":null,"is_oa":false,"landing_page_url":"http://merrimackpharma.com/sites/default/files/documents/SABCS2014_563_Sachdev%20et%20al_v7.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048816829","https://openalex.org/W1565366196","https://openalex.org/W2405639273","https://openalex.org/W4385554503","https://openalex.org/W4319057676","https://openalex.org/W2048777642","https://openalex.org/W2584534704","https://openalex.org/W2066374585","https://openalex.org/W4385545308","https://openalex.org/W2593132556"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}